2-(2-FLUOROBENZYL)-1,5-DIMETHYL-4-NITRO-1H-PYRAZOL-3(2H)-ONE, 95.0%, 250mg

(R)-2-Fluoro-5-methyl-N-(4-(4-(morpholin-2-ylmethoxy)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)benzenesulfonamide hydrochloride, 5mg

N-(2-BROMO-5-CHLORO-4-METHYLPHENYL)ACETAMIDE, 95.0%, 25g

(2S,5S)-tert-butyl 5-(3-bromo-5-((diethoxyphosphoryl)methyl)benzyl)-2-(tert-butyl)-3-methyl-4-oxoimidazolidine-1-carboxylate, 98%, 250mg

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester, 97%, 25g

Methyl 2-Amino-5-bromonicotinate, 95.0%, 1g

4-Chloro-8-methyl-2-(trifluoromethyl)quinoline, 95.0%, 1g

Pipette graduate tipo 3, classe AS, 1 ml, divisione, 0,01 ml, estremità con tappo in cotone, no, 12 pezzi

4-Bromo-1-naphthalenol, 95.0%, 25g

(S)-tert-Butyl 2-methylpyrrolidine-1-carboxylate, 95.0%, 1g

Pipette volumetriche 1 marca classe B, 50 ml, 6 pezzi

4-Methyl-morpholin-3-one, 95.0%, 5g

D-Phenylalaninol>98.0%(GC)(T)25g